Shivani Shinde, Ram Prasad Sahu

Stories by Shivani Shinde, Ram Prasad Sahu

'Sun Pharma offers the best medium- to long-term earnings growth visibility'

'Sun Pharma offers the best medium- to long-term earnings growth visibility'

Rediff.com   3 Apr 2023

India's largest listed pharmaceutical (pharma) company - Sun Pharmaceutical Industries (Sun Pharma) - is expected to maintain its outperformance vis--vis the sector's, as its multiple bets on specialty products, improving product mix, recent acquisitions, and branded business are finding favour with brokerages. While it has gained 7 per cent over the past year, the Nifty Pharma Index is down 13.6 per cent. Its outperformance over two years has been fairly evident, with the market leader gaining 66 per cent to Nifty Pharma's minus 1.4 per cent.

Should you buy stocks of Page Industries?

Should you buy stocks of Page Industries?

Rediff.com   31 Mar 2023

Since its October high last year, the stock of innerwear major Page Industries has been on a downtrend, shedding a little over 30 per cent of its market value. Higher competitive intensity, muted volumes, pressure on margins, and rich valuations have led to downgrades for the stock. The October-December quarter (third quarter, or Q3) performance was lower than the Street's expectations - both on volumes/sales and margins.

Why Zydus is likely to continue with its outperformance

Why Zydus is likely to continue with its outperformance

Rediff.com   31 Mar 2023

Even as most of its large-cap pharmaceutical peers have struggled to stay above water on the returns front, Zydus Lifesciences has been one of the big outperformers within the sector over the past year with a return of over 30 per cent. The gains have come on the back of multiple triggers such as the scaling up of new product launches in the US market, clearance for its Moraiya (Gujarat) facility and steady performance in the domestic market. Though it has been the top pharma gainer in the 2022-23 financial year (FY23), brokerages continue to maintain their 'buy' stance, given the strong visibility in the US market.

Factors that will sustain Abbott outperformance

Factors that will sustain Abbott outperformance

Rediff.com   22 Mar 2023

Abbott India outperformed the Indian pharmaceutical market (IPM) with a year-on-year (YoY) growth of 23 per cent in February. The domestic market grew at a robust 20 per cent on a low base, primarily led by volume growth and price hikes. Abbott continued to outperform the sector in the anti-diabetic space with a growth of 20 per cent and key brands such as Thyronorm (hypothyroidism), biliary agent Udiliv, insulin Ryzodeg posted robust growth.

SVB fallout: Fintech, venture capital companies come to the rescue

SVB fallout: Fintech, venture capital companies come to the rescue

Rediff.com   20 Mar 2023

Fintech and venture capital firms such as Recur Club, Razorpay and Trifecta Capital have come to the aid of homegrown start-ups caught in the crossfire of the Silicon Valley Bank fiasco. Alternative funding platform Recur Club said it was allocating $15 million to all Indian founders affected by the crisis. It will not charge any platform fee for the same.

10 Safe Stocks To Bet In Volatile Market

10 Safe Stocks To Bet In Volatile Market

Rediff.com   20 Mar 2023

10 high dividend paying stocks across sectors that are expected to maintain or even increase their pay-outs in FY23 thanks to faster earnings growth in the last four quarters.

FMEG: Most brokerages positive on cable & wires business

FMEG: Most brokerages positive on cable & wires business

Rediff.com   18 Mar 2023

With raw material prices rising sequentially in Q4 FY23, margins of fast moving electrical goods (FMEG) companies could witness pressure as they refrain from hiking prices and demand remains soft. Transition to a new regulatory regime-fans moved to new BEE standards from January 1-poses additional risk for firms. Business depends on volume trends in summer for key sub-segments, which account for a significant chunk of the sector's overall sales pie.

Meet K Krithivasan, TCS' CEO-designate

Meet K Krithivasan, TCS' CEO-designate

Rediff.com   17 Mar 2023

"Humble", "kind", and "spiritual" are some adjectives used to describe K Krithivasan, chief executive officer designate and global head of banking, financial services, and insurance business, Tata Consultancy Services (TCS), where he is an old stager. Krithivasan, based out of Chennai, has been part of the global technology sector for over 34 years. He joined TCS in 1989. During his long tenure at the company, he has held leadership roles in delivery, customer relationship management, large programme management, and sales.

Improving outlook, upgrades to keep wheels turning for auto companies

Improving outlook, upgrades to keep wheels turning for auto companies

Rediff.com   13 Mar 2023

The S&P BSE Auto Index has been one of the biggest outperformers among sectoral indices over the past year with returns of 26 per cent. By comparison, the benchmarks - the National Stock Exchange Nifty50 and the S&P BSE Sensex - managed about 6-8 per cent during this period. Improving demand, falling raw material costs, and rising product realisations, led by the premiumisation of portfolios, have led to a revision of growth estimates and upgrades by domestic brokerages.

D-Street cautious on Aditya Birla Fashion amid weak performance

D-Street cautious on Aditya Birla Fashion amid weak performance

Rediff.com   10 Mar 2023

The stock of Aditya Birla Fashion Retail is down 10 per cent from its February high. Even as the revenue performance of the apparel retail major in the October-December quarter's for the 2022-23 financial year (Q3FY23) was better than expected, the company saw brokerage downgrades, given the weak operating performance and the pressure on margins. This the second consecutive quarter of margin miss despite strong traction on the sales front.

El Nino effect: Agrochem companies may face near-term headwinds

El Nino effect: Agrochem companies may face near-term headwinds

Rediff.com   6 Mar 2023

Domestic-focused agricultural chemical (agrochem) companies could face near-term headwinds, given the worries on the El Nio effect on monsoons, higher inventory, and pressure on margins. Some of these were reflected in the October-December quarter (third quarter, or Q3) results of companies and may impact them in the current quarter (fourth quarter, or Q4) as well. Nuvama Research pointed out that the sector witnessed mixed performance during the quarter as global agrochem and domestic fertiliser companies maintained growth momentum, while adverse agronomical conditions and excess channel inventory weighed on domestic market volume offtake.

1.5 Million Vacancies In Cybersecurity!

1.5 Million Vacancies In Cybersecurity!

Rediff.com   3 Mar 2023

'The skilling gap is a serious issue.' 'We partner with the government on skilling, but as a company we have several skilling programmes, and we work closely with the partner ecosystem.

VC model of investment looks like ponzi scheme: N R Narayana Murthy

VC model of investment looks like ponzi scheme: N R Narayana Murthy

Rediff.com   3 Mar 2023

N R Narayana Murthy, co-founder of Infosys, blamed the venture capitalist community for inculcating a culture among entrepreneurs to chase growth at all costs. He said the VC model of investment looked like a ponzi scheme. "I would hold venture capitalists responsible who propounded the theory that only the top-line is important and not the bottom-line. "I think that is completely wrong. In many ways it looks like a ponzi scheme.

Why stocks of listed REITs are risky bets in the near term

Why stocks of listed REITs are risky bets in the near term

Rediff.com   28 Feb 2023

In addition to the negative sentiment as a consequence of changes announced in the Union Budget 2023-24 concerning tax treatment for debt repayment distribution, concerns about hiring slowdown and its leasing impact, as well as higher interest rates, could blight the sector in the near term.

Wipro freshers' dilemma: Work for half the salary or wait longer

Wipro freshers' dilemma: Work for half the salary or wait longer

Rediff.com   21 Feb 2023

Information technology major Wipro has asked candidates who have successfully completed their training and who were offered Rs 6.5 lakh per annum earlier whether they would be willing to take up projects for an annual compensation of Rs 3.5 lakh. Wipro told Business Standard that it had to adjust its onboarding plans "in the light of the changing macro environment and, as a result, our business needs". "Like others in our industry, we continue to assess global economies and customer needs, which factor in our hiring plans.

Infosys, Wipro Are Not Hiring Freshers This Year

Infosys, Wipro Are Not Hiring Freshers This Year

Rediff.com   21 Feb 2023

Industry players said IT hiring was not as strong as it was in 2022. One reason is the high bench IT firms have due to earlier hiring.

Want ChatGPT to Write Love Letters?

Want ChatGPT to Write Love Letters?

Rediff.com   16 Feb 2023

78% Indians were unable to tell the difference between a love letter written by ChatGPT and one by a human being.

Apply for Maharashtra licence in 3 weeks, SC tells Uber

Apply for Maharashtra licence in 3 weeks, SC tells Uber

Rediff.com   14 Feb 2023

The Supreme Court on Monday directed Uber to apply for a licence within three weeks to operate in Maharashtra, stressing that cab aggregators cannot function without one. A bench led by Chief Justice of India (CJI) D Y Chandrachud said that an earlier interim order by the Supreme Court that had allowed Uber to operate in the state would not provide legal cover, since an aggregator cannot operate without a licence. It ordered Uber to apply for a licence by March 6, said a report by Bar and Bench.

How Cognizant plans to become an employer of choice

How Cognizant plans to become an employer of choice

Rediff.com   13 Feb 2023

'Winning a deal is one aspect, making sure that we are able to execute it profitably is also important' says Rajesh Nambiar.

After record store additions in Q3, Metro Brands' growth outperformance may continue

After record store additions in Q3, Metro Brands' growth outperformance may continue

Rediff.com   29 Jan 2023

The country's largest listed footwear brand by market capitalisation, Metro Brands, posted better than expected December quarter results for the 2022-23 financial year (FY23), riding on store expansion and strong same store sales (SSS) growth. Profitability too remained robust, even as net profit growth was marginally lower. The company, which retails across the Metro, Mochi, Walkway, Crocs and Fitflop formats, posted a 24 per cent growth in revenues over Q3FY22.